INS and Hyperglycemia: Indeed, an early switch to basal insulin analogues may be recommended, in line with recent studies suggesting that early initiation of this therapy may provide sustained long-term glycemic control, that is improved compared with standard of care, thus offering persons with T2DM more effective protection from the toxic effects of hyperglycemia [12].